Chapman Rowan E
SEC Form 4 insider trading activity
Chapman Rowan E has filed 9 SEC Form 4 filings (16 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Jul 18, 2026.
On the most recent filing, Chapman Rowan E is listed as Director at Natera, Inc. Inside the rolling window, Chapman Rowan E reported no open-market purchases and 4 open-market sales totaling $1.8M in NTRA. The largest disclosed transaction in the window is a sale of 4,366 NTRA shares on Dec 5, 2025, worth $1.1M.
Companies traded
Other insiders at NTRA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.8M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Aug 28, 2025 | NTRA | Sale | $459K |
Frequently asked questions
How many SEC Form 4 filings has Chapman Rowan E made?
Chapman Rowan E has filed 9 SEC Form 4 filings (16 transaction rows) across 1 company since 2025.
Which companies does Chapman Rowan E trade?
Chapman Rowan E has filed SEC Form 4 disclosures for 1 company, including NTRA.
When was Chapman Rowan E's most recent SEC Form 4 filing?
Chapman Rowan E's most recent SEC Form 4 filing on Tracefour is dated Jul 18, 2026.
What is Chapman Rowan E's total buy and sell value in the current window?
Inside the rolling retention window, Chapman Rowan E bought $0 and sold $1.8M based on SEC Form 4 filings.
What was Chapman Rowan E's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,366 NTRA shares on 2025-12-05, worth $1.1M, per SEC Form 4 filings.